The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.